Research graph
References from Primary breast diffuse large B-cell lymphoma mimicking breast carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and etiology of diffuse large B-cell lymphoma.
10.1053/j.seminhematol.2023.11.004 · 2023 · External reference
Primary breast diffuse large B-cell lymphoma in an immunocompetent male.
10.1016/j.amjmed.2024.11.009 · 2025 · External reference
Clinical features and outcomes of primary breast diffuse large B-cell lymphoma: a matched-pair study.
10.1177/11795549231203142 · 2023 · External reference
Case-based review of breast lymphomas.
10.1007/s40134-024-00425-8 · 2024 · External reference
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
10.1038/s41591-018-0016-8 · 2018 · External reference
Diffuse large B-cell lymphoma.
10.1056/nejmra2027612 · 2021 · External reference
R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma: a propensity matched population-based study.
10.1002/ajh.27151 · 2024 · External reference
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre rare cancer network study.
10.1186/1471-2407-8-86 · 2008 · External reference
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
10.1093/annonc/mdm471 · 2008 · External reference
Primary large B-cell lymphomas of immune-privileged sites.
10.1182/blood.2023020911 · 2024 · External reference
Primary diffuse large B cell lymphoma of the lactating left breast. A case report and review of the literature.
2020 · External reference
Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review.
2015 · External reference
Primary breast lymphoma.
10.1016/j.ctrv.2014.05.010 · 2014 · External reference
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features.
10.1259/bjr/78413721 · 2012 · External reference
International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data.
10.1182/blood.2022015850 · 2022 · External reference
Double-hit large B cell lymphoma.
10.1007/s11912-017-0629-y · 2017 · External reference
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.
10.1016/s1470-2045(15)00005-4 · 2015 · External reference
Advances in multi-omics study of prognostic biomarkers of diffuse large B-cell lymphoma.
10.7150/ijbs.67892 · 2022 · External reference
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
10.1182/blood-2016-01-643569 · 2016 · External reference
PET/CT in non-Hodgkin lymphoma: an update.
10.1053/j.semnuclmed.2022.11.001 · 2023 · External reference
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure.
10.1111/cas.13828 · 2018 · External reference
First-line treatment for primary breast diffuse large B-cell lymphoma using immunochemotherapy and central nervous system prophylaxis: a multicenter phase 2 trial.
10.3390/cancers12082192 · 2020 · External reference
Primary breast diffuse large B-cell lymphoma in the rituximab era: a retrospective study of the Chinese Southwest Oncology Group.
10.1002/cam4.6686 · 2023 · External reference
Stand-alone intrathecal central nervous system prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
10.1111/bjh.16070 · 2019 · External reference
R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma: a propensity matched population-based study.
10.1002/ajh.27151 · ExternalCitation · doi-reference
Primary breast diffuse large B-cell lymphoma in the rituximab era: a retrospective study of the Chinese Southwest Oncology Group.
10.1002/cam4.6686 · ExternalCitation · doi-reference
Double-hit large B cell lymphoma.
10.1007/s11912-017-0629-y · ExternalCitation · doi-reference
Case-based review of breast lymphomas.
10.1007/s40134-024-00425-8 · ExternalCitation · doi-reference
Primary breast diffuse large B-cell lymphoma in an immunocompetent male.
10.1016/j.amjmed.2024.11.009 · ExternalCitation · doi-reference
Primary breast lymphoma.
10.1016/j.ctrv.2014.05.010 · ExternalCitation · doi-reference
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas.
10.1016/s1470-2045(15)00005-4 · ExternalCitation · doi-reference
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
10.1038/s41591-018-0016-8 · ExternalCitation · doi-reference
Epidemiology and etiology of diffuse large B-cell lymphoma.
10.1053/j.seminhematol.2023.11.004 · ExternalCitation · doi-reference
PET/CT in non-Hodgkin lymphoma: an update.
10.1053/j.semnuclmed.2022.11.001 · ExternalCitation · doi-reference
Diffuse large B-cell lymphoma.
10.1056/nejmra2027612 · ExternalCitation · doi-reference
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
10.1093/annonc/mdm471 · ExternalCitation · doi-reference
Stand-alone intrathecal central nervous system prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
10.1111/bjh.16070 · ExternalCitation · doi-reference
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure.
10.1111/cas.13828 · ExternalCitation · doi-reference
Clinical features and outcomes of primary breast diffuse large B-cell lymphoma: a matched-pair study.
10.1177/11795549231203142 · ExternalCitation · doi-reference
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
10.1182/blood-2016-01-643569 · ExternalCitation · doi-reference
International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data.
10.1182/blood.2022015850 · ExternalCitation · doi-reference
Primary large B-cell lymphomas of immune-privileged sites.
10.1182/blood.2023020911 · ExternalCitation · doi-reference
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre rare cancer network study.
10.1186/1471-2407-8-86 · ExternalCitation · doi-reference
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features.
10.1259/bjr/78413721 · ExternalCitation · doi-reference
First-line treatment for primary breast diffuse large B-cell lymphoma using immunochemotherapy and central nervous system prophylaxis: a multicenter phase 2 trial.
10.3390/cancers12082192 · ExternalCitation · doi-reference
Advances in multi-omics study of prognostic biomarkers of diffuse large B-cell lymphoma.
10.7150/ijbs.67892 · ExternalCitation · doi-reference
